HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth R LaMontagne Selected Research

Kenneth R LaMontagne Research Topics

Disease

2Neoplasms (Cancer)
01/2009 - 02/2006
1Neoplasm Metastasis (Metastasis)
01/2009
1Corneal Neovascularization
01/2009
1Breast Neoplasms (Breast Cancer)
02/2006

Drug/Important Bio-Agent (IBA)

1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2009
11- (4- (6- amino- 5- (methoxyiminomethyl)pyrimidin- 4- yloxy)- 2- chlorophenyl)- 3- ethylureaIBA
01/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2009
1ErythropoietinFDA Link
02/2006
1epoetin betaIBA
02/2006
1Paclitaxel (Taxol)FDA LinkGeneric
02/2006
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
02/2006

Therapy/Procedure

1Therapeutics
02/2006